查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
放射性醫藥品注射器的全球市場:成長趨勢與競爭的分析(2023年～2029年)
市場調查報告書
商品編碼
1325275

放射性醫藥品注射器的全球市場:成長趨勢與競爭的分析(2023年～2029年)

Global Radiopharmaceutical Injector Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
出版日期: | 出版商: QYResearch | 英文 162 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球放射性醫藥品注射器的市場規模將從2022年的2,721萬美元到2029年達到4,618萬美元，在預測期間(2023年～2029年)時將以年複合成長率7.35％的速度成長。

本報告提供全球放射性醫藥品注射器市場相關調查分析，提供市場規模與預測，地區和市場區隔的分析，企業簡介等資訊。

目錄

第1章 報告概要

  • 放射性醫藥品注射器定義
  • 市場:各類型
    • 全球放射性醫藥品注射器的市場規模成長率:各類型(2018年·2022年·2029年)
    • PET放射性醫藥品注射器
    • PET·SPECT放射性醫藥品注射器
  • 市場:各用途
    • 全球放射性醫藥品注射器的市場規模成長率:各用途(2018年·2022年·2029年)
    • 醫院，診療所
    • 研究開發機關
  • 前提條件與限制
  • 調查目的
  • 研究涵蓋年數

第2章 全球放射性醫藥品注射器的銷售額

  • 全球放射性醫藥品注射器的收益的估計與預測(2018年～2029年)
  • 全球放射性醫藥品注射器的收益:各地區(2018年·2022年·2029年)
  • 全球放射性醫藥品注射器的收益:各地區
    • 全球放射性醫藥品注射器的收益:各地區(2018年～2023年)
    • 全球放射性醫藥品注射器的收益:各地區(2024年～2029年)
  • 全球放射性醫藥品注射器的銷售數量的估計與預測(2018年～2029年)
  • 全球放射性醫藥品注射器的銷售數量:各地區(2018年·2022年·2029年)
  • 全球放射性醫藥品注射器的銷售數量:各地區
    • 全球放射性醫藥品注射器的銷售數量:各地區(2018年～2023年)
    • 全球放射性醫藥品注射器的銷售數量:各地區(2024年～2029年)
  • 北美
  • 歐洲
  • 日本
  • 中國
  • 亞太地區(中國和日本以外)
  • 中東·非洲·南美

第3章 全球生產(生產據點為基礎的)

  • 全球放射性醫藥品注射器生產能力(2018年～2029年)
  • 全球放射性醫藥品注射器生產:各地區(2018年·2022年·2029年)
  • 全球放射性醫藥品注射器生產:各地區
    • 全球放射性醫藥品注射器生產實際成果:各地區(2018年～2023年)
    • 全球放射性醫藥品注射器生產預測:各地區(2024年～2029年)
    • 北美
    • 歐洲
    • 日本

第4章 競爭:各製造廠商

  • 全球放射性醫藥品注射器的銷售數量:各製造廠商
    • 全球放射性醫藥品注射器的銷售數量:各製造廠商(2021年～2023年)
    • 全球放射性醫藥品注射器的銷售數量佔有率:各製造廠商(2021年～2023年)
  • 全球放射性醫藥品注射器的收益:各製造廠商
    • 全球放射性醫藥品注射器的收益:各製造廠商(2021年～2023年)
    • 全球放射性醫藥品注射器的收益佔有率:各製造廠商(2021年～2023年)
  • 全球放射性醫藥品注射器的銷售價格:各製造廠商
  • 競爭情形的分析
    • 製造商市場集中度(CR5)
    • 全球放射性醫藥品注射器的市場佔有率:各類型企業(1級，2級，3級)
  • 全球放射性醫藥品注射器的主要製造商，主要市場區域和總公司
  • 全球放射性醫藥品注射器的主要製造商，提供產品
  • 全球放射性醫藥品注射器的主要製造商，產業進入日

第5章 估計與預測:各類型

  • 全球放射性醫藥品注射器的銷售數量:各類型
    • 全球放射性醫藥品注射器的銷售數量的實際成果:各類型(2018年～2023年)
    • 全球放射性醫藥品注射器的銷售數量的預測:各類型(2024年～2029年)
    • 全球放射性醫藥品注射器的銷售數量的市場佔有率:各類型(2018年～2029年)
  • 全球放射性醫藥品注射器的收益:各類型
    • 全球放射性醫藥品注射器的收益的實際成果:各類型(2018年～2023年)
    • 全球放射性醫藥品注射器的收益的預測:各類型(2024年～2029年)
    • 全球放射性醫藥品注射器的收益的市場佔有率:各類型(2018年～2029年)
  • 全球放射性醫藥品注射器的價格:各類型
    • 全球放射性醫藥品注射器的價格:各類型(2018年～2023年)
    • 全球放射性醫藥品注射器的價格的預測:各類型(2024年～2029年)

第6章 市場規模:各用途

  • 全球放射性醫藥品注射器的銷售數量:各用途
    • 全球放射性醫藥品注射器的銷售數量的實際成果:各用途(2018年～2023年)
    • 全球放射性醫藥品注射器的銷售數量的預測:各用途(2024年～2029年)
    • 全球放射性醫藥品注射器的銷售數量的市場佔有率:各用途(2018年～2029年)
  • 全球放射性醫藥品注射器的收益:各用途
    • 全球放射性醫藥品注射器的收益的實際成果:各用途(2018年～2023年)
    • 全球放射性醫藥品注射器的收益的預測:各用途(2024年～2029年)
    • 全球放射性醫藥品注射器的收益的市場佔有率:各用途(2018年～2029年)
  • 全球放射性醫藥品注射器的價格:各用途
    • 全球放射性醫藥品注射器的價格:各用途(2018年～2023年)
    • 全球放射性醫藥品注射器的價格的預測:各用途(2024年～2029年)

第7章 北美

  • 北美的放射性醫藥品注射器的銷售額:各企業
    • 北美的放射性醫藥品注射器的銷售數量:各企業(2021年～2023年)
    • 北美的放射性醫藥品注射器的收益:各企業(2021年～2023年)
  • 北美的放射性醫藥品注射器的市場規模:各類型
    • 北美的放射性醫藥品注射器的銷售數量:各類型(2018年～2029年)
    • 北美的放射性醫藥品注射器的銷售額佔有率:各類型(2018年～2029年)
  • 北美的放射性醫藥品注射器的市場規模:各用途
    • 北美的放射性醫藥品注射器的銷售數量:各用途(2018年～2029年)
    • 北美的放射性醫藥品注射器的銷售額佔有率:各用途(2018年～2029年)
  • 北美的放射性醫藥品注射器的市場規模:各國
    • 北美的放射性醫藥品注射器的收益:各國(2018年·2022年·2029年)
    • 北美的放射性醫藥品注射器的收益:各國(2018年～2029年)
    • 北美的放射性醫藥品注射器的銷售數量:各國(2018年～2029年)
    • 美國
    • 加拿大
    • 墨西哥

第8章 歐洲

  • 歐洲的放射性醫藥品注射器的銷售額:各企業
    • 歐洲的放射性醫藥品注射器的銷售數量:各企業(2021年～2023年)
    • 歐洲的放射性醫藥品注射器的收益:各企業(2021年～2023年)
  • 歐洲的放射性醫藥品注射器的市場規模:各類型
    • 歐洲的放射性醫藥品注射器的銷售額:各類型(2018年～2029年)
    • 歐洲的放射性醫藥品注射器的銷售額佔有率:各類型(2018年～2029年)
  • 歐洲的放射性醫藥品注射器的市場規模:各用途
    • 歐洲的放射性醫藥品注射器的銷售數量:各用途(2018年～2029年)
    • 歐洲的放射性醫藥品注射器的銷售額佔有率:各用途(2018年～2029年)
  • 歐洲的放射性醫藥品注射器的市場規模:各國
    • 歐洲的放射性醫藥品注射器的收益:各國(2018年·2022年·2029年)
    • 歐洲的放射性醫藥品注射器的收益:各國(2018年～2029年)
    • 歐洲的放射性醫藥品注射器的銷售數量:各國(2018年～2029年)
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷比盧三國

第9章 中國

  • 中國的放射性醫藥品注射器的銷售額:各企業
    • 中國的放射性醫藥品注射器的銷售數量:各企業(2021年～2023年)
    • 中國的放射性醫藥品注射器的收益:各企業(2021年～2023年)
  • 中國的放射性醫藥品注射器的市場規模:各類型
    • 中國的放射性醫藥品注射器的銷售額:各類型(2018年～2029年)
    • 中國的放射性醫藥品注射器的銷售額佔有率:各類型(2018年～2029年)
  • 中國的放射性醫藥品注射器的市場規模:各用途
    • 中國的放射性醫藥品注射器的銷售額:各用途(2018年～2029年)
    • 中國的放射性醫藥品注射器的銷售額佔有率:各用途(2018年～2029年)

第10章 日本

  • 日本的放射性醫藥品注射器的銷售額:各企業
    • 日本的放射性醫藥品注射器的銷售數量:各企業(2021年～2023年)
    • 日本的放射性醫藥品注射器的銷售額:各企業(2021年～2023年)
  • 日本的放射性醫藥品注射器的市場規模:各類型
    • 日本的放射性醫藥品注射器的銷售額:各類型(2018年～2029年)
    • 日本的放射性醫藥品注射器的銷售額佔有率:各類型(2018年～2029年)
  • 日本的放射性醫藥品注射器的市場規模:各用途
    • 日本的放射性醫藥品注射器的銷售額:各用途(2018年～2029年)
    • 日本的放射性醫藥品注射器的銷售額佔有率:各用途(2018年～2029年)

第11章 亞太地區(中國和日本以外)

  • 亞太地區的放射性醫藥品注射器的銷售額:各企業
    • 亞太地區的放射性醫藥品注射器的銷售數量:各企業(2021年～2023年)
    • 亞太地區的放射性醫藥品注射器的收益:各企業(2021年～2023年)
  • 亞太地區的放射性醫藥品注射器的市場規模:各類型
    • 亞太地區的放射性醫藥品注射器的銷售額:各類型(2018年～2029年)
    • 亞太地區的放射性醫藥品注射器的銷售額佔有率:各類型(2018年～2029年)
  • 亞太地區的放射性醫藥品注射器的市場規模:各用途
    • 亞太地區的放射性醫藥品注射器的銷售額:各用途(2018年～2029年)
    • 亞太地區的放射性醫藥品注射器的銷售額佔有率:各用途(2018年～2029年)
  • 亞太地區的放射性醫藥品注射器的市場規模:各地區
    • 亞太地區的放射性醫藥品注射器的收益:各地區(2018年·2022年·2029年)
    • 亞太地區的放射性醫藥品注射器的收益:各地區(2018年～2029年)
    • 亞太地區的放射性醫藥品注射器的銷售數量:各地區(2018年～2029年)
    • 韓國
    • 東南亞
    • 印度

第12章 中東·非洲·南美

  • 中東·非洲·南美的放射性醫藥品注射器的銷售額:各企業
    • 中東·非洲·南美的放射性醫藥品注射器的銷售數量:各企業(2021年～2023年)
    • 中東·非洲·南美的放射性醫藥品注射器的收益:各企業(2021年～2023年)
  • 中東·非洲·南美的放射性醫藥品注射器的市場規模:各類型
    • 中東·非洲·南美的放射性醫藥品注射器的銷售數量:各類型(2018年～2029年)
    • 中東·非洲·南美的放射性醫藥品注射器的銷售額佔有率:各類型(2018年～2029年)
  • 中東·非洲·南美的放射性醫藥品注射器的市場規模:各用途
    • 中東·非洲·南美的放射性醫藥品注射器的銷售數量:各用途(2018年～2029年)
    • 中東·非洲·南美的放射性醫藥品注射器的銷售額佔有率:各用途(2018年～2029年)
  • 中東·非洲·南美的放射性醫藥品注射器的市場規模:各國
    • 中東·非洲·南美的放射性醫藥品注射器的收益:各國(2018年·2022年·2029年)
    • 中東·非洲·南美的放射性醫藥品注射器的收益:各國(2018年～2029年)
    • 中東·非洲·南美的放射性醫藥品注射器的銷售數量:各國(2018年～2029年)

第13章 企業簡介

  • Medrad, Inc. (Bayer)
  • UNIVERSAL GIKEN
  • Comecer
  • Sumitomo Heavy Industries
  • Tema Sinergie
  • Lemer Pax
  • BQSV

第14章 價值鏈和銷售管道的分析

  • 放射性醫藥品注射器的價值鏈分析
  • 放射性醫藥品注射器主要的原料
    • 主要的原料
    • 原料的主要供應商
  • 放射性醫藥品注射器的生產方式和流程
  • 放射性醫藥品注射器的銷售與行銷
    • 放射性醫藥品注射器的銷售管道
    • 放射性醫藥品注射器的銷售商
  • 放射性醫藥品注射器客戶

第15章 放射性醫藥品注射器的市場動態

  • 放射性醫藥品注射器產業趨勢
  • 放射性醫藥品注射器市場促進因素
  • 放射性醫藥品注射器市場課題
  • 放射性醫藥品注射器市場阻礙因素

第16章 主要調查結果

第17章 附錄

The Radiopharmaceutical Injector market was valued at US$ 27.21 million in 2022 and is projected to reach US$ 46.18 million by 2029, at a CAGR of 7.35% during the forecast period (2023-2029).

The global key manufacturers of Radiopharmaceutical Injector include: Medrad, Inc.(Bayer), UNIVERSAL GIKEN, Comecer, Sumitomo Heavy Industries, Tema Sinergie, Lemer Pax, BQSV, and etc. In 2022, the global top five players hold a share approximately 84.23% in sales volume, and in term of revenue of Radiopharmaceutical Injector, the top five companies hold a share nearly 84.93%.

In terms of production side, this report researches the Radiopharmaceutical Injector capacity, production, growth rate, market share by manufacturers and regional level and country level, from 2018 to 2023, and forecast to 2029.

In terms of sales (consumption) side, this report focuses on the sales of Radiopharmaceutical Injector by regions (Countries), company, by Type and by Application. from 2018 to 2023 and forecast to 2029.

The global Radiopharmaceutical Injector market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Radiopharmaceutical Injector market. These figures have been provided in terms of both revenue and volume for the period 2018-2029. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

By Company

  • Medrad, Inc.(Bayer)
  • UNIVERSAL GIKEN
  • Comecer
  • Sumitomo Heavy Industries
  • Tema Sinergie
  • Lemer Pax
  • BQSV

Segment by Type

  • PET Radioactive Drugs Injector
  • PET and SPECT Radioactive Drugs Injector

Segment by Application

  • Hospitals and Clinics
  • R&D Institution

Production by Region

  • North America
  • Europe
  • Japan

Sales by Region

  • North America
  • United States
  • Canada
  • Mexico
  • China
  • Japan
  • APAC (excluding China and Japan)
  • South Korea
  • Southeast Asia
  • India
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Benelux
  • Middle East & Africa, South America

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Radiopharmaceutical Injector in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Radiopharmaceutical Injector production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
  • Chapter 4: Detailed analysis of Radiopharmaceutical Injector manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by company, by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: Europe by company, by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: China by company, by Type, and by Application, sales, and revenue for each segment.
  • Chapter 10: APAC (excluding China) by company, by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East, Africa, and South America by company, by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiopharmaceutical Injector sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 15: The main points and conclusions of the report.

Table of Contents

1 Report Overview

  • 1.1 Radiopharmaceutical Injector Definition
  • 1.2 Market by Type
    • 1.2.1 Global Radiopharmaceutical Injector Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 PET Radioactive Drugs Injector
    • 1.2.3 PET and SPECT Radioactive Drugs Injector
  • 1.3 Market by Application
    • 1.3.1 Global Radiopharmaceutical Injector Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Hospitals and Clinics
    • 1.3.3 R&D Institution
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Radiopharmaceutical Injector Sales

  • 2.1 Global Radiopharmaceutical Injector Revenue Estimates and Forecasts 2018-2029
  • 2.2 Global Radiopharmaceutical Injector Revenue by Region: 2018 VS 2022 VS 2029
  • 2.3 Global Radiopharmaceutical Injector Revenue by Region
    • 2.3.1 Global Radiopharmaceutical Injector Revenue by Region (2018-2023)
    • 2.3.2 Global Radiopharmaceutical Injector Revenue by Region (2024-2029)
  • 2.4 Global Radiopharmaceutical Injector Sales Quantity Estimates and Forecasts 2018-2029
  • 2.5 Global Radiopharmaceutical Injector Sales Quantity by Region: 2018 VS 2022 VS 2029
  • 2.6 Global Radiopharmaceutical Injector Sales Quantity by Region
    • 2.6.1 Global Radiopharmaceutical Injector Sales Quantity by Region (2018-2023)
    • 2.6.2 Global Radiopharmaceutical Injector Sales Quantity by Region (2024-2029)
  • 2.7 North America
  • 2.8 Europe
  • 2.9 Japan
  • 2.10 China
  • 2.11 APAC (excluding China and Japan)
  • 2.12 Middle East, Africa and South America

3 Global Production (Based on Production Site)

  • 3.1 Global Radiopharmaceutical Injector Production Capacity (2018-2029)
  • 3.2 Global Radiopharmaceutical Injector Production by Region: 2018 VS 2022 VS 2029
  • 3.3 Global Radiopharmaceutical Injector Production by Region
    • 3.3.1 Global Radiopharmaceutical Injector Historic Production by Region (2018-2023)
    • 3.3.2 Global Radiopharmaceutical Injector Forecasted Production by Region (2024-2029)
    • 3.3.3 North America
    • 3.3.4 Europe
    • 3.3.5 Japan

4 Competition by Manufacturers

  • 4.1 Global Radiopharmaceutical Injector Sales Quantity by Manufacturers
    • 4.1.1 Global Radiopharmaceutical Injector Sales Quantity by Manufacturers (2021-2023)
    • 4.1.2 Global Radiopharmaceutical Injector Sales Quantity Share by Manufacturers (2021-2023)
  • 4.2 Global Radiopharmaceutical Injector Revenue by Manufacturers
    • 4.2.1 Global Radiopharmaceutical Injector Revenue by Manufacturers (2021-2023)
    • 4.2.2 Global Radiopharmaceutical Injector Revenue Share by Manufacturers (2021-2023)
  • 4.3 Global Radiopharmaceutical Injector Sales Price by Manufacturers
  • 4.4 Analysis of Competitive Landscape
    • 4.4.1 Manufacturers Market Concentration Ratio (CR5)
    • 4.4.2 Global Radiopharmaceutical Injector Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 4.5 Global Key Manufacturers of Radiopharmaceutical Injector, Major Market Areas and Headquarters
  • 4.6 Global Key Manufacturers of Radiopharmaceutical Injector, Product Offered
  • 4.7 Global Key Manufacturers of Radiopharmaceutical Injector, Date of Enter into This Industry

5 Estimates and Forecasts by Type

  • 5.1 Global Radiopharmaceutical Injector Sales Quantity by Type
    • 5.1.1 Global Radiopharmaceutical Injector Historical Sales Quantity by Type (2018-2023)
    • 5.1.2 Global Radiopharmaceutical Injector Forecasted Sales Quantity by Type (2024-2029)
    • 5.1.3 Global Radiopharmaceutical Injector Sales Quantity Market Share by Type (2018-2029)
  • 5.2 Global Radiopharmaceutical Injector Revenue by Type
    • 5.2.1 Global Radiopharmaceutical Injector Historical Revenue by Type (2018-2023)
    • 5.2.2 Global Radiopharmaceutical Injector Forecasted Revenue by Type (2024-2029)
    • 5.2.3 Global Radiopharmaceutical Injector Revenue Market Share by Type (2018-2029)
  • 5.3 Global Radiopharmaceutical Injector Price by Type
    • 5.3.1 Global Radiopharmaceutical Injector Price by Type (2018-2023)
    • 5.3.2 Global Radiopharmaceutical Injector Price Forecast by Type (2024-2029)

6 Market Size by Application

  • 6.1 Global Radiopharmaceutical Injector Sales Quantity by Application
    • 6.1.1 Global Radiopharmaceutical Injector Historical Sales Quantity by Application (2018-2023)
    • 6.1.2 Global Radiopharmaceutical Injector Forecasted Sales Quantity by Application (2024-2029)
    • 6.1.3 Global Radiopharmaceutical Injector Sales Quantity Market Share by Application (2018-2029)
  • 6.2 Global Radiopharmaceutical Injector Revenue by Application
    • 6.2.1 Global Radiopharmaceutical Injector Historical Revenue by Application (2018-2023)
    • 6.2.2 Global Radiopharmaceutical Injector Forecasted Revenue by Application (2024-2029)
    • 6.2.3 Global Radiopharmaceutical Injector Revenue Market Share by Application (2018-2029)
  • 6.3 Global Radiopharmaceutical Injector Price by Application
    • 6.3.1 Global Radiopharmaceutical Injector Price by Application (2018-2023)
    • 6.3.2 Global Radiopharmaceutical Injector Price Forecast by Application (2024-2029)

7 North America

  • 7.1 North America Radiopharmaceutical Injector Sales by Company
    • 7.1.1 North America Radiopharmaceutical Injector Sales Quantity by Company (2021-2023)
    • 7.1.2 North America Radiopharmaceutical Injector Revenue by Company (2021-2023)
  • 7.2 North America Radiopharmaceutical Injector Market Size by Type
    • 7.2.1 North America Radiopharmaceutical Injector Sales Quantity by Type (2018-2029)
    • 7.2.2 North America Radiopharmaceutical Injector Sales Share by Type (2018-2029)
  • 7.3 North America Radiopharmaceutical Injector Market Size by Application
    • 7.3.1 North America Radiopharmaceutical Injector Sales Quantity by Application (2018-2029)
    • 7.3.2 North America Radiopharmaceutical Injector Sales Share by Application (2018-2029)
  • 7.4 North America Radiopharmaceutical Injector Market Size by Country
    • 7.4.1 North America Radiopharmaceutical Injector Revenue by Country: 2018 VS 2022 VS 2029
    • 7.4.2 North America Radiopharmaceutical Injector Revenue by Country (2018-2029)
    • 7.4.3 North America Radiopharmaceutical Injector Sales Quantity by Country (2018-2029)
    • 7.4.4 United States
    • 7.4.5 Canada
    • 7.4.6 Mexico

8 Europe

  • 8.1 Europe Radiopharmaceutical Injector Sales by Company
    • 8.1.1 Europe Radiopharmaceutical Injector Sales Quantity by Company (2021-2023)
    • 8.1.2 Europe Radiopharmaceutical Injector Revenue by Company (2021-2023)
  • 8.2 Europe Radiopharmaceutical Injector Market Size by Type
    • 8.2.1 Europe Radiopharmaceutical Injector Sales by Type (2018-2029)
    • 8.2.2 Europe Radiopharmaceutical Injector Sales Share by Type (2018-2029)
  • 8.3 Europe Radiopharmaceutical Injector Market Size by Application
    • 8.3.1 Europe Radiopharmaceutical Injector Sales Quantity by Application (2018-2029)
    • 8.3.2 Europe Radiopharmaceutical Injector Sales Share by Application (2018-2029)
  • 8.4 Europe Radiopharmaceutical Injector Market Size by Country
    • 8.4.1 Europe Radiopharmaceutical Injector Revenue by Country: 2018 VS 2022 VS 2029
    • 8.4.2 Europe Radiopharmaceutical Injector Revenue by Country (2018-2029)
    • 8.4.3 Europe Radiopharmaceutical Injector Sales Quantity by Country (2018-2029)
    • 8.4.4 Germany
    • 8.4.5 France
    • 8.4.6 U.K.
    • 8.4.7 Italy
    • 8.4.8 Benelux

9 China

  • 9.1 China Radiopharmaceutical Injector Sales by Company
    • 9.1.1 China Radiopharmaceutical Injector Sales Quantity by Company (2021-2023)
    • 9.1.2 China Radiopharmaceutical Injector Revenue by Company (2021-2023)
  • 9.2 China Radiopharmaceutical Injector Market Size by Type
    • 9.2.1 China Radiopharmaceutical Injector Sales by Type (2018-2029)
    • 9.2.2 China Radiopharmaceutical Injector Sales Share by Type (2018-2029)
  • 9.3 China Radiopharmaceutical Injector Market Size by Application
    • 9.3.1 China Radiopharmaceutical Injector Sales by Application (2018-2029)
    • 9.3.2 China Radiopharmaceutical Injector Sales Share by Application (2018-2029)

10 Japan

  • 10.1 Japan Radiopharmaceutical Injector Sales by Company
    • 10.1.1 Japan Radiopharmaceutical Injector Sales Quantity by Company (2021-2023)
    • 10.1.2 Japan Radiopharmaceutical Injector Revenue by Company (2021-2023)
  • 10.2 Japan Radiopharmaceutical Injector Market Size by Type
    • 10.2.1 Japan Radiopharmaceutical Injector Sales by Type (2018-2029)
    • 10.2.2 Japan Radiopharmaceutical Injector Sales Share by Type (2018-2029)
  • 10.3 Japan Radiopharmaceutical Injector Market Size by Application
    • 10.3.1 Japan Radiopharmaceutical Injector Sales by Application (2018-2029)
    • 10.3.2 Japan Radiopharmaceutical Injector Sales Share by Application (2018-2029)

11 APAC (excluding China and Japan)

  • 11.1 APAC Radiopharmaceutical Injector Sales by Company
    • 11.1.1 APAC Radiopharmaceutical Injector Sales Quantity by Company (2021-2023)
    • 11.1.2 APAC Radiopharmaceutical Injector Revenue by Company (2021-2023)
  • 11.2 APAC Radiopharmaceutical Injector Market Size by Type
    • 11.2.1 APAC Radiopharmaceutical Injector Sales by Type (2018-2029)
    • 11.2.2 APAC Radiopharmaceutical Injector Sales Share by Type (2018-2029)
  • 11.3 APAC Radiopharmaceutical Injector Market Size by Application
    • 11.3.1 APAC Radiopharmaceutical Injector Sales by Application (2018-2029)
    • 11.3.2 APAC Radiopharmaceutical Injector Sales Share by Application (2018-2029)
  • 11.4 APAC Radiopharmaceutical Injector Market Size by Region
    • 11.4.1 APAC Radiopharmaceutical Injector Revenue by Region: 2018 VS 2022 VS 2029
    • 11.4.2 APAC Radiopharmaceutical Injector Revenue by Region (2018-2029)
    • 11.4.3 APAC Radiopharmaceutical Injector Sales Quantity by Region (2018-2029)
    • 11.4.4 South Korea
    • 11.4.5 Southeast Asia
    • 11.4.6 India

12 Middle East, Africa and South America

  • 12.1 Middle East, Africa and South America Radiopharmaceutical Injector Sales by Company
    • 12.1.1 Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Company (2021-2023)
    • 12.1.2 Middle East, Africa and South America Radiopharmaceutical Injector Revenue by Company (2021-2023)
  • 12.2 Middle East, Africa and South America Radiopharmaceutical Injector Market Size by Type
    • 12.2.1 Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Type (2018-2029)
    • 12.2.2 Middle East, Africa and South America Radiopharmaceutical Injector Sales Share by Type (2018-2029)
  • 12.3 Middle East, Africa and South America Radiopharmaceutical Injector Market Size by Application
    • 12.3.1 Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Application (2018-2029)
    • 12.3.2 Middle East, Africa and South America Radiopharmaceutical Injector Sales Share by Application (2018-2029)
  • 12.4 Middle East, Africa and South America Radiopharmaceutical Injector Market Size by Country
    • 12.4.1 Middle East, Africa and South America Radiopharmaceutical Injector Revenue by Country: 2018 VS 2022 VS 2029
    • 12.4.2 Middle East, Africa and South America Radiopharmaceutical Injector Revenue by Country (2018-2029)
    • 12.4.3 Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Country (2018-2029)

13 Company Profiles

  • 13.1 Medrad, Inc.(Bayer)
    • 13.1.1 Medrad, Inc.(Bayer) Company Information
    • 13.1.2 Medrad, Inc.(Bayer) Overview
    • 13.1.3 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
    • 13.1.4 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Products and Services
  • 13.2 UNIVERSAL GIKEN
    • 13.2.1 UNIVERSAL GIKEN Company Information
    • 13.2.2 UNIVERSAL GIKEN Overview
    • 13.2.3 UNIVERSAL GIKEN Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
    • 13.2.4 UNIVERSAL GIKEN Radiopharmaceutical Injector Products and Services
  • 13.3 Comecer
    • 13.3.1 Comecer Company Information
    • 13.3.2 Comecer Overview
    • 13.3.3 Comecer Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
    • 13.3.4 Comecer Radiopharmaceutical Injector Products and Services
  • 13.4 Sumitomo Heavy Industries
    • 13.4.1 Sumitomo Heavy Industries Company Information
    • 13.4.2 Sumitomo Heavy Industries Overview
    • 13.4.3 Sumitomo Heavy Industries Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
    • 13.4.4 Sumitomo Heavy Industries Radiopharmaceutical Injector Products and Services
  • 13.5 Tema Sinergie
    • 13.5.1 Tema Sinergie Company Information
    • 13.5.2 Tema Sinergie Overview
    • 13.5.3 Tema Sinergie Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
    • 13.5.4 Tema Sinergie Radiopharmaceutical Injector Products and Services
  • 13.6 Lemer Pax
    • 13.6.1 Lemer Pax Company Information
    • 13.6.2 Lemer Pax Overview
    • 13.6.3 Lemer Pax Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
    • 13.6.4 Lemer Pax Radiopharmaceutical Injector Products and Services
  • 13.7 BQSV
    • 13.7.1 BQSV Company Information
    • 13.7.2 BQSV Overview
    • 13.7.3 BQSV Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
    • 13.7.4 BQSV Radiopharmaceutical Injector Products and Services

14 Value Chain and Sales Channels Analysis

  • 14.1 Radiopharmaceutical Injector Value Chain Analysis
  • 14.2 Radiopharmaceutical Injector Key Raw Materials
    • 14.2.1 Key Raw Materials
    • 14.2.2 Raw Materials Key Suppliers
  • 14.3 Radiopharmaceutical Injector Production Mode & Process
  • 14.4 Radiopharmaceutical Injector Sales and Marketing
    • 14.4.1 Radiopharmaceutical Injector Sales Channels
    • 14.4.2 Radiopharmaceutical Injector Distributors
  • 14.5 Radiopharmaceutical Injector Customers

15 Radiopharmaceutical Injector Market Dynamics

  • 15.1 Radiopharmaceutical Injector Industry Trends
  • 15.2 Radiopharmaceutical Injector Market Drivers
  • 15.3 Radiopharmaceutical Injector Market Challenges
  • 15.4 Radiopharmaceutical Injector Market Restraints

16 Key Findings

17 Appendix

  • 17.1 Research Methodology
    • 17.1.1 Methodology/Research Approach
    • 17.1.2 Data Source
  • 17.2 Author Details
  • 17.3 Disclaimer

List of Tables

  • Table 1. Global Radiopharmaceutical Injector Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of PET and SPECT Radioactive Drugs Injector
  • Table 3. Global Radiopharmaceutical Injector Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 4. Global Radiopharmaceutical Injector Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 5. Global Radiopharmaceutical Injector Revenue by Region (2018-2023) & (US$ Million)
  • Table 6. Global Radiopharmaceutical Injector Revenue Market Share by Region (2018-2023)
  • Table 7. Global Radiopharmaceutical Injector Revenue by Region (2024-2029) & (US$ Million)
  • Table 8. Global Radiopharmaceutical Injector Revenue Market Share by Region (2024-2029)
  • Table 9. Global Radiopharmaceutical Injector Sales Quantity by Region: 2018 VS 2022 VS 2029 (Units)
  • Table 10. Global Radiopharmaceutical Injector Sales Quantity by Region (2018-2023) & (Units)
  • Table 11. Global Radiopharmaceutical Injector Sales Quantity Market Share by Region (2018-2023)
  • Table 12. Global Radiopharmaceutical Injector Sales Quantity by Region (2024-2029) & (Units)
  • Table 13. Global Radiopharmaceutical Injector Sales Quantity Market Share by Region (2024-2029)
  • Table 14. Global Radiopharmaceutical Injector Production Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (Units)
  • Table 15. Global Radiopharmaceutical Injector Production by Region (2018-2023) & (Units)
  • Table 16. Global Radiopharmaceutical Injector Production Market Share by Region (2018-2023)
  • Table 17. Global Radiopharmaceutical Injector Production by Region (2024-2029) & (Units)
  • Table 18. Global Radiopharmaceutical Injector Production Market Share by Region (2024-2029)
  • Table 19. Global Radiopharmaceutical Injector Sales Quantity by Manufacturers (2021-2023) & (Units)
  • Table 20. Global Radiopharmaceutical Injector Sales Quantity Share by Manufacturers (2021-2023)
  • Table 21. Global Radiopharmaceutical Injector Revenue by Manufacturers (2021-2023) & (US$ Million)
  • Table 22. Global Radiopharmaceutical Injector Revenue Share by Manufacturers (2021-2023)
  • Table 23. Global Radiopharmaceutical Injector Price by Manufacturers 2018-2023 (K USD/Unit)
  • Table 24. Global Radiopharmaceutical Injector Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 25. Global Radiopharmaceutical Injector by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Injector as of 2022)
  • Table 26. Global Key Manufacturers of Radiopharmaceutical Injector, Major Market Areas and Headquarters
  • Table 27. Global Key Manufacturers of Radiopharmaceutical Injector, Product Offered
  • Table 28. Global Key Manufacturers of Radiopharmaceutical Injector, Date of Enter into This Industry
  • Table 29. Global Radiopharmaceutical Injector Sales Quantity by Type (2018-2023) & (Units)
  • Table 30. Global Radiopharmaceutical Injector Sales Quantity by Type (2024-2029) & (Units)
  • Table 31. Global Radiopharmaceutical Injector Sales Quantity Share by Type (2018-2023)
  • Table 32. Global Radiopharmaceutical Injector Sales Quantity Share by Type (2024-2029)
  • Table 33. Global Radiopharmaceutical Injector Revenue by Type (2018-2023) & (US$ Million)
  • Table 34. Global Radiopharmaceutical Injector Revenue by Type (2024-2029) & (US$ Million)
  • Table 35. Global Radiopharmaceutical Injector Revenue Share by Type (2018-2023)
  • Table 36. Global Radiopharmaceutical Injector Revenue Share by Type (2024-2029)
  • Table 37. Radiopharmaceutical Injector Price by Type (2018-2023) & (K USD/Unit)
  • Table 38. Global Radiopharmaceutical Injector Price Forecast by Type (2024-2029) & (K USD/Unit)
  • Table 39. Global Radiopharmaceutical Injector Sales Quantity by Application (2018-2023) & (Units)
  • Table 40. Global Radiopharmaceutical Injector Sales Quantity by Application (2024-2029) & (Units)
  • Table 41. Global Radiopharmaceutical Injector Sales Quantity Share by Application (2018-2023)
  • Table 42. Global Radiopharmaceutical Injector Sales Quantity Share by Application (2024-2029)
  • Table 43. Global Radiopharmaceutical Injector Revenue by Application (2018-2023) & (US$ Million)
  • Table 44. Global Radiopharmaceutical Injector Revenue by Application (2024-2029) & (US$ Million)
  • Table 45. Global Radiopharmaceutical Injector Revenue Share by Application (2018-2023)
  • Table 46. Global Radiopharmaceutical Injector Revenue Share by Application (2024-2029)
  • Table 47. Radiopharmaceutical Injector Price by Application (2018-2023) & (K USD/Unit)
  • Table 48. Global Radiopharmaceutical Injector Price Forecast by Application (2024-2029) & (K USD/Unit)
  • Table 49. North America Radiopharmaceutical Injector Sales Quantity by Company (2021-2023) & (Units)
  • Table 50. North America Radiopharmaceutical Injector Sales Quantity Market Share by Company (2021-2023)
  • Table 51. North America Radiopharmaceutical Injector Revenue by Company (2021-2023) & (US$ Million)
  • Table 52. North America Radiopharmaceutical Injector Revenue Market Share by Company (2021-2023)
  • Table 53. North America Radiopharmaceutical Injector Sales Quantity by Type (2018-2023) & (Units)
  • Table 54. North America Radiopharmaceutical Injector Sales Quantity by Type (2024-2029) & (Units)
  • Table 55. North America Radiopharmaceutical Injector Sales Share by Type (2018-2023)
  • Table 56. North America Radiopharmaceutical Injector Sales Share by Type (2024-2029)
  • Table 57. North America Radiopharmaceutical Injector Sales Quantity by Application (2018-2023) & (Units)
  • Table 58. North America Radiopharmaceutical Injector Sales Quantity by Application (2024-2029) & (Units)
  • Table 59. North America Radiopharmaceutical Injector Sales Share by Application (2018-2023) & (US$ Million)
  • Table 60. North America Radiopharmaceutical Injector Sales Share by Application (2024-2029) & (US$ Million)
  • Table 61. North America Radiopharmaceutical Injector Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 62. North America Radiopharmaceutical Injector Revenue by Country (2018-2023) & (US$ Million)
  • Table 63. North America Radiopharmaceutical Injector Revenue by Country (2024-2029) & (US$ Million)
  • Table 64. North America Radiopharmaceutical Injector Sales Quantity by Country (2018-2023) & (Units)
  • Table 65. North America Radiopharmaceutical Injector Sales Quantity by Country (2024-2029) & (Units)
  • Table 66. Europe Radiopharmaceutical Injector Sales Quantity by Company (2021-2023) & (Units)
  • Table 67. Europe Radiopharmaceutical Injector Sales Quantity Market Share by Company (2021-2023)
  • Table 68. Europe Radiopharmaceutical Injector Revenue by Company (2021-2023) & (US$ Million)
  • Table 69. Europe Radiopharmaceutical Injector Revenue Market Share by Company (2021-2023)
  • Table 70. Europe Radiopharmaceutical Injector Sales by Type (2018-2023) & (Units)
  • Table 71. Europe Radiopharmaceutical Injector Sales by Type (2024-2029) & (Units)
  • Table 72. Europe Radiopharmaceutical Injector Sales Share by Type (2018-2023)
  • Table 73. Europe Radiopharmaceutical Injector Sales Share by Type (2024-2029)
  • Table 74. Europe Radiopharmaceutical Injector Sales Quantity by Application (2018-2023) & (Units)
  • Table 75. Europe Radiopharmaceutical Injector Sales Quantity by Application (2024-2029) & (Units)
  • Table 76. Europe Radiopharmaceutical Injector Sales Share by Application (2018-2023) & (US$ Million)
  • Table 77. Europe Radiopharmaceutical Injector Sales Share by Application (2024-2029) & (US$ Million)
  • Table 78. Europe Radiopharmaceutical Injector Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 79. Europe Radiopharmaceutical Injector Revenue by Country (2018-2023) & (US$ Million)
  • Table 80. Europe Radiopharmaceutical Injector Revenue by Country (2024-2029) & (US$ Million)
  • Table 81. Europe Radiopharmaceutical Injector Sales Quantity by Country (2018-2023) & (Units)
  • Table 82. Europe Radiopharmaceutical Injector Sales Quantity by Country (2024-2029) & (Units)
  • Table 83. China Radiopharmaceutical Injector Sales Quantity by Company (2021-2023) & (Units)
  • Table 84. China Radiopharmaceutical Injector Sales Quantity Market Share by Company (2021-2023)
  • Table 85. China Radiopharmaceutical Injector Revenue by Company (2021-2023) & (US$ Million)
  • Table 86. China Radiopharmaceutical Injector Revenue Market Share by Company (2021-2023)
  • Table 87. China Radiopharmaceutical Injector Sales by Type (2018-2023) & (Units)
  • Table 88. China Radiopharmaceutical Injector Sales by Type (2024-2029) & (Units)
  • Table 89. China Radiopharmaceutical Injector Sales Share by Type (2018-2023)
  • Table 90. China Radiopharmaceutical Injector Sales Share by Type (2024-2029)
  • Table 91. China Radiopharmaceutical Injector Sales by Application (2018-2023) & (Units)
  • Table 92. China Radiopharmaceutical Injector Sales by Application (2024-2029) & (Units)
  • Table 93. China Radiopharmaceutical Injector Sales Share by Application (2018-2023) & (US$ Million)
  • Table 94. China Radiopharmaceutical Injector Sales Share by Application (2024-2029) & (US$ Million)
  • Table 95. Japan Radiopharmaceutical Injector Sales Quantity by Company (2021-2023) & (Units)
  • Table 96. Japan Radiopharmaceutical Injector Sales Quantity Market Share by Company (2021-2023)
  • Table 97. Japan Radiopharmaceutical Injector Revenue by Company (2021-2023) & (US$ Million)
  • Table 98. Japan Radiopharmaceutical Injector Revenue Market Share by Company (2021-2023)
  • Table 99. Japan Radiopharmaceutical Injector Sales by Type (2018-2023) & (Units)
  • Table 100. Japan Radiopharmaceutical Injector Sales by Type (2024-2029) & (Units)
  • Table 101. Japan Radiopharmaceutical Injector Sales Share by Type (2018-2023)
  • Table 102. Japan Radiopharmaceutical Injector Sales Share by Type (2024-2029)
  • Table 103. Japan Radiopharmaceutical Injector Sales by Application (2018-2023) & (Units)
  • Table 104. Japan Radiopharmaceutical Injector Sales by Application (2024-2029) & (Units)
  • Table 105. Japan Radiopharmaceutical Injector Sales Share by Application (2018-2023) & (US$ Million)
  • Table 106. Japan Radiopharmaceutical Injector Sales Share by Application (2024-2029) & (US$ Million)
  • Table 107. APAC Radiopharmaceutical Injector Sales Quantity by Company (2021-2023) & (Units)
  • Table 108. APAC Radiopharmaceutical Injector Sales Quantity Market Share by Company (2018-2023)
  • Table 109. APAC Radiopharmaceutical Injector Revenue by Company (2021-2023) & (US$ Million)
  • Table 110. APAC Radiopharmaceutical Injector Revenue Market Share by Company (2021-2023)
  • Table 111. APAC Radiopharmaceutical Injector Sales by Type (2018-2023) & (Units)
  • Table 112. APAC Radiopharmaceutical Injector Sales by Type (2024-2029) & (Units)
  • Table 113. APAC Radiopharmaceutical Injector Sales Share by Type (2018-2023)
  • Table 114. APAC Radiopharmaceutical Injector Sales Share by Type (2024-2029)
  • Table 115. APAC Radiopharmaceutical Injector Sales by Application (2018-2023) & (Units)
  • Table 116. APAC Radiopharmaceutical Injector Sales by Application (2024-2029) & (Units)
  • Table 117. APAC Radiopharmaceutical Injector Sales Share by Application (2018-2023) & (US$ Million)
  • Table 118. APAC Radiopharmaceutical Injector Sales Share by Application (2024-2029) & (US$ Million)
  • Table 119. APAC Radiopharmaceutical Injector Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 120. APAC Radiopharmaceutical Injector Revenue by Region (2018-2023) & (US$ Million)
  • Table 121. APAC Radiopharmaceutical Injector Revenue by Region (2024-2029) & (US$ Million)
  • Table 122. APAC Radiopharmaceutical Injector Sales Quantity by Region (2018-2023) & (Units)
  • Table 123. APAC Radiopharmaceutical Injector Sales Quantity by Region (2024-2029) & (Units)
  • Table 124. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Company (2021-2023) & (Units)
  • Table 125. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity Market Share by Company (2021-2023)
  • Table 126. Middle East, Africa and South America Radiopharmaceutical Injector Revenue by Company (2021-2023) & (US$ Million)
  • Table 127. Middle East, Africa and South America Radiopharmaceutical Injector Revenue Market Share by Company (2021-2023)
  • Table 128. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Type (2018-2023) & (Units)
  • Table 129. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Type (2024-2029) & (Units)
  • Table 130. Middle East, Africa and South America Radiopharmaceutical Injector Sales Share by Type (2018-2023)
  • Table 131. Middle East, Africa and South America Radiopharmaceutical Injector Sales Share by Type (2024-2029)
  • Table 132. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Application (2018-2023) & (Units)
  • Table 133. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Application (2024-2029) & (Units)
  • Table 134. Middle East, Africa and South America Radiopharmaceutical Injector Sales Share by Application (2018-2023) & (US$ Million)
  • Table 135. Middle East, Africa and South America Radiopharmaceutical Injector Sales Share by Application (2024-2029) & (US$ Million)
  • Table 136. Middle East, Africa and South America Radiopharmaceutical Injector Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 137. Middle East, Africa and South America Radiopharmaceutical Injector Revenue by Country (2018-2023) & (US$ Million)
  • Table 138. Middle East, Africa and South America Radiopharmaceutical Injector Revenue by Country (2024-2029) & (US$ Million)
  • Table 139. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Country (2018-2023) & (Units)
  • Table 140. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Country (2024-2029) & (Units)
  • Table 141. Medrad, Inc.(Bayer) Company Information
  • Table 142. Medrad, Inc.(Bayer) Description and Overview
  • Table 143. Medrad, Inc.(Bayer) Radiopharmaceutical Injector Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) & (K USD/Unit) and Gross Margin (2021-2023)
  • Table 144. Medrad, Inc.(Bayer) Radiopharmaceutical Injector Products and Services
  • Table 145. UNIVERSAL GIKEN Company Information
  • Table 146. UNIVERSAL GIKEN Description and Overview
  • Table 147. UNIVERSAL GIKEN Radiopharmaceutical Injector Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) & (K USD/Unit) and Gross Margin (2021-2023)
  • Table 148. UNIVERSAL GIKEN Radiopharmaceutical Injector Products and Services
  • Table 149. Comecer Company Information
  • Table 150. Comecer Description and Overview
  • Table 151. Comecer Radiopharmaceutical Injector Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) & (K USD/Unit) and Gross Margin (2021-2023)
  • Table 152. Comecer Radiopharmaceutical Injector Products and Services
  • Table 153. Sumitomo Heavy Industries Company Information
  • Table 154. Sumitomo Heavy Industries Description and Overview
  • Table 155. Sumitomo Heavy Industries Radiopharmaceutical Injector Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) & (K USD/Unit) and Gross Margin (2021-2023)
  • Table 156. Sumitomo Heavy Industries Radiopharmaceutical Injector Products and Services
  • Table 157. Tema Sinergie Company Information
  • Table 158. Tema Sinergie Description and Overview
  • Table 159. Tema Sinergie Radiopharmaceutical Injector Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) & (K USD/Unit) and Gross Margin (2021-2023)
  • Table 160. Tema Sinergie Radiopharmaceutical Injector Products and Services
  • Table 161. Lemer Pax Company Information
  • Table 162. Lemer Pax Description and Overview
  • Table 163. Lemer Pax Radiopharmaceutical Injector Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) & (K USD/Unit) and Gross Margin (2021-2023)
  • Table 164. Lemer Pax Radiopharmaceutical Injector Products and Services
  • Table 165. BQSV Company Information
  • Table 166. BQSV Description and Overview
  • Table 167. BQSV Radiopharmaceutical Injector Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) & (K USD/Unit) and Gross Margin (2021-2023)
  • Table 168. BQSV Radiopharmaceutical Injector Products and Services
  • Table 169. Raw Materials Key Suppliers Lists
  • Table 170. Radiopharmaceutical Injector Distributors List
  • Table 171. Radiopharmaceutical Injector Customers List
  • Table 172. Research Programs/Design for This Report
  • Table 173. Key Data Information from Secondary Sources
  • Table 174. Key Data Information from Primary Sources
  • Table 175. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

  • Figure 1. Radiopharmaceutical Injector Product Picture
  • Figure 2. Global Radiopharmaceutical Injector Market Share by Type in 2022 & 2029
  • Figure 3. PET Radioactive Drugs Injector Product Picture
  • Figure 4. Major Manufacturers of PET Radioactive Drugs Injector
  • Figure 5. PET and SPECT Radioactive Drugs Injector Product Picture
  • Figure 6. Global Radiopharmaceutical Injector Market Share by Application in 2022 & 2029
  • Figure 7. Hospitals and Clinics
  • Figure 8. R&D Institution
  • Figure 9. Radiopharmaceutical Injector Report Years Considered
  • Figure 10. Global Radiopharmaceutical Injector Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 11. Global Radiopharmaceutical Injector Revenue 2018-2029 (US$ Million)
  • Figure 12. Global Radiopharmaceutical Injector Sales Quantity 2018-2029 (Units)
  • Figure 13. North America Radiopharmaceutical Injector Sales Quantity YoY (2018-2029) & (Units)
  • Figure 14. North America Radiopharmaceutical Injector Revenue YoY (2018-2029) & (US$ Million)
  • Figure 15. Europe Radiopharmaceutical Injector Sales Quantity YoY (2018-2029) & (Units)
  • Figure 16. Europe Radiopharmaceutical Injector Revenue YoY (2018-2029) & (US$ Million)
  • Figure 17. Japan Radiopharmaceutical Injector Sales Quantity YoY (2018-2029) & (Units)
  • Figure 18. Japan Radiopharmaceutical Injector Revenue YoY (2018-2029) & (US$ Million)
  • Figure 19. China Radiopharmaceutical Injector Sales Quantity YoY (2018-2029) & (Units)
  • Figure 20. China Radiopharmaceutical Injector Revenue YoY (2018-2029) & (US$ Million)
  • Figure 21. APAC Radiopharmaceutical Injector Sales Quantity YoY (2018-2029) & (Units)
  • Figure 22. APAC Radiopharmaceutical Injector Revenue YoY (2018-2029) & (US$ Million)
  • Figure 23. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity YoY (2018-2029) & (Units)
  • Figure 24. Middle East, Africa and South America Radiopharmaceutical Injector Revenue YoY (2018-2029) & (US$ Million)
  • Figure 25. Global Radiopharmaceutical Injector Capacity, Production and Utilization (2018-2029) & (Units)
  • Figure 26. Radiopharmaceutical Injector Production Growth Rate in North America (2018-2029) & (Units)
  • Figure 27. Radiopharmaceutical Injector Production Growth Rate in Europe (2018-2029) & (Units)
  • Figure 28. Radiopharmaceutical Injector Production Growth Rate in Japan (2018-2029) & (Units)
  • Figure 29. North America Radiopharmaceutical Injector Revenue Share by Country in 2022
  • Figure 30. North America Radiopharmaceutical Injector Sales Share by Country in 2022
  • Figure 31. United States Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 32. Canada Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 33. Mexico Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 34. Europe Radiopharmaceutical Injector Revenue Share by Country in 2022
  • Figure 35. Europe Radiopharmaceutical Injector Sales Quantity Share by Country in 2022
  • Figure 36. Germany Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 37. France Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 38. U.K. Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 39. Italy Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 40. Benelux Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 41. APAC Radiopharmaceutical Injector Revenue Share by Region in 2022
  • Figure 42. South Korea Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 43. Southeast Asia Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 44. India Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 45. Middle East, Africa and South America Radiopharmaceutical Injector Revenue Share by Country in 2022
  • Figure 46. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity Share by Country in 2022
  • Figure 47. Radiopharmaceutical Injector Value Chain
  • Figure 48. Radiopharmaceutical Injector Production Process
  • Figure 49. Channels of Distribution (Direct Vs Distribution)
  • Figure 50. Distributors Profiles
  • Figure 51. Bottom-up and Top-down Approaches for This Report
  • Figure 52. Data Triangulation
  • Figure 53. Key Executives Interviewed